MYX
Click for more information
0.88% $4.56 mayne pharma group limited

The FDA asked Mayne and Mithra for additional bioequivalence...

  1. jamarco
    525 Posts.
    lightbulb Created with Sketch. 160
    clock Created with Sketch.
    10/01/20
    13:10
    Post #: 42319909
    The FDA asked Mayne and Mithra for additional bioequivalence data in comparison to Nuvaring. From what I have read, it looks like the FDA now have 2 months to respond again to Mayne, either with approval, additional questions or rejection. Anything is possible, but my strong assumption is that Mayne will have provided all of the necessary information and the FDA will approve. Time will tell.
    MYX Price at posting: 46.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

IMU Imugene doses first cancer patient in Oasis trial
right-arrow Created with Sketch.
JGH Jade's strong gas exploration results another step towards Mongolian development
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
AML Cultural heritage agreement puts Walford Creek exploration back on the map
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
(20min delay)
Last
$4.56 		Change
0.040(0.88%) 		Mkt cap ! $387.9M
Open High Low Value Volume
$4.54 $4.64 $4.50 $1.094M 239.3K

Buyers (Bids)

No. Vol. Price($)
1 176 $4.54
 

Sellers (Offers)

Price($) Vol. No.
$4.58 860 2
View Market Depth
Last trade - 16.10pm 25/06/2024 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.